Ed Silverman

Patient advocates and some experts are expressing growing alarm over the perceived risks of a Neurocrine Biosciences rare disease drug

The FDA flagged a potential safety signal after four patient deaths in a trial testing a schizophrenia drug, Argenx faces an unusual setback, and more pharma news.

PhRMA is suing the Trump administration, smaller biotech firms are frustrated over tariffs, and more of the latest pharma news.

The Justice Department issued a new directive for combating fraud that noted the agency will pursue violations of a federal law that tightly regulates the pharmaceutical industry.

The World Health Organization released its first guidelines addressing the sharp rise in obesity among children and adolescents

Vaxcyte said its pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up a competition with Pfizer and Merck

A final Medicare rule aimed at lowering prices for doctor-administered drugs applies to only four companies and saves 96% less than the initial proposal

Novo has agreed to pay up to $2.6 billion to license an experimental, weekly weight loss pill from China’s Hengrui Pharma

Some lawmakers are urging the Trump administration to rethink a pending rule that may prevent Americans from obtaining medicines from licensed international pharmacies.

Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.